The German Constitutional Courtroom issued a landmark determination with implications for a lot of corporations doing enterprise in Europe on July 9, 2021. For many years, the European Fee and EU member states strived to create a pan-European Unified Patent Courtroom (UPC). After overcoming many hurdles, any wise commentator can be cautious in making statements about the way forward for the UPC. That mentioned, for the primary time in years it now seems that the pan-European patent litigation system might lastly come into being. That is notably related for corporations from the life sciences sector that are likely to implement their blockbuster patents in parallel proceedings in probably the most related jurisdictions. The brand new system and the supply of pan-European injunctions signifies that claimants will be capable of transfer from 5 parallel instances to at least one. Nonetheless, the brand new system additionally comes with disadvantages equivalent to pan-European invalidation proceedings. No person can predict the standard of judgments issued by the longer term court docket. For house owners of European patents who’re involved about shedding their IP rights, now could be the time to determine the crown jewels and to make an knowledgeable determination about opting out.